Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial.
Articolo
Data di Pubblicazione:
2013
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Raffi, F; Jaeger, H; QUIROS ROLDAN, Maria Eugenia; Albrecht, H; Belonosova, E; Gatell, Jm; Baril, Jg; Domingo, P; Brennan, C; Almond, S; Min, S; on behalf of the extended SPRING, 2 Study Group
Link alla scheda completa:
Pubblicato in: